Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II

Frontiers in Medicine

Medicine

Aikaterini Patsatsi¹  Soheil Tavakolpour²  Maryam Daneshpazhooh³  Hamidreza Mahmoudi³  Dedee F. Murrell⁴ 

[1] Autoimmune Skin and Bullous Diseases Unit, 2nd Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece;Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States;Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran;Department of Dermatology, St George Hospital, University of New South Wales, Sydney, NSW, Australia;

关键词: COVID-19;    SARS-CoV-2;    psoriasis;    vaccination;    autoimmune bullous diseases;    vitamin D;    rituximab;    pregnancy;   

DOI  :  10.3389/fmed.2023.1268285

 received in 2023-07-27, accepted in 2023-08-11,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Patsatsi, Daneshpazhooh, Tavakolpour, Mahmoudi and Murrell.